Unraveling the drug resistance web in IBD: The gut microbiota-immunity-epigenetics axis

Qing Li, Mingrong Cheng, Xiaoyue Wang, Weiwei Li, Feng Zhang · 2026

Read Unraveling the drug resistance web in IBD: The gut microbiota-immunity-epigenetics axis by Qing Li, Mingrong Cheng, Xiaoyue Wang, Weiwei Li, Feng Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13540173.txt.

Description

Qing Li, Mingrong Cheng, Xiaoyue Wang, Weiwei Li, and Feng Zhang published a 2026 review on why drugs stop working in inflammatory bowel disease, or IBD. Resistance to modern precision treatments is a major barrier for patients. Older studies usually blamed a single molecule or pathway.

The authors describe a web of three interacting systems: the gut microbiota, the immune system, and epigenetics, the chemical marks that control gene activity. They review resistance to key medicines, including anti-TNF biologics, vedolizumab, and JAK inhibitors. Their model casts disturbed gut microbes as the initiator, immune disorder as the amplifier, and epigenetic change as a third loop. Seeing resistance as a system may reveal new ways to restore drug response.

Catalog record

CREATORQing Li, Mingrong Cheng, Xiaoyue Wang, Weiwei Li, Feng Zhang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE94 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13540173

Browse the full library · About the Tower of Babel